Other Viruses Citation List:
May 13 - May 26, 2011
Human Cytomegalovirus
1. Early Inhibitors of Human Cytomegalovirus: State-of-Art and Therapeutic Perspectives. Mercorelli, B., D. Lembo, G. Palu, and A. Loregian. Pharmacology & Therapeutics, 2011. [Epub ahead of print]; PMID[21570424].
[PubMed]. OV_0513-052611.
2. Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA Polymerase. Zahn, K.E., E.P. Tchesnokov, M. Gotte, and S. Doublie. The Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21566148].
[PubMed]. OV_0513-052611.
3. New Prodrugs of Adefovir and Cidofovir. Tichy, T., G. Andrei, M. Dracinsky, A. Holy, J. Balzarini, R. Snoeck, and M. Krecmerova. Bioorganic & Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21565516].
[PubMed]. OV_0513-052611.
Hepatitis C virus
4. Sar Studies on a Series of N-Benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: Potent Inhibitors of the Polymerase Enzyme (NS5B) of the Hepatitis C Virus. Gentles, R.G., M. Ding, X. Zheng, L. Chupak, M.A. Poss, B.R. Beno, L. Pelosi, M. Liu, J. Lemm, Y.K. Wang, S. Roberts, M. Gao, and J. Kadow. Bioorganic & Medicinal Chemistry Letters, 2011. 21(10): p. 3142-7; PMID[21450465].
[PubMed]. OV_0513-052611.
5. Novel, Potent, and Orally Bioavailable Phosphinic Acid Inhibitors of the Hepatitis C Virus NS3 Protease. Clarke, M.O., X. Chen, A. Cho, W.E.t. Delaney, E. Doerffler, M. Fardis, M. Ji, M. Mertzman, R. Pakdaman, H.J. Pyun, T. Rowe, C.Y. Yang, X.C. Sheng, and C.U. Kim. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21601450].
[PubMed]. OV_0513-052611.
6. Activity and the Metabolic Activation Pathway of the Potent and Selective Hepatitis C Virus Pronucleotide Inhibitor Psi-353661. Furman, P.A., E. Murakami, C. Niu, A.M. Lam, C. Espiritu, S. Bansal, H. Bao, T. Tolstykh, H. Micolochick Steuer, M. Keilman, V. Zennou, N. Bourne, R.L. Veselenak, W. Chang, B.S. Ross, J. Du, M.J. Otto, and M.J. Sofia. Antiviral Research, 2011. [Epub ahead of print]; PMID[21600932].
[PubMed]. OV_0513-052611.
7. Inhibition of Hepatitis C Virus 3a Genotype Entry through Glanthus Nivalis Agglutinin. Ashfaq, U.A., M.S. Masoud, S. Khaliq, Z. Nawaz, and S. Riazuddin. Virology Journal, 2011. 8(1): p. 248; PMID[21599979].
[PubMed]. OV_0513-052611.
8. Distinct Functions of NS5A in HCV RNA Replication Uncovered by Studies with the Ns5a Inhibitor Bms-790052. Fridell, R.A., D. Qiu, L. Valera, C. Wang, R.E. Rose, and M. Gao. Journal of Virology, 2011. [Epub ahead of print]; PMID[21593143].
[PubMed]. OV_0513-052611.
9. Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures. Lemm, J.A., J.E. Leet, D.R. O'Boyle, 2nd, J.L. Romine, X.S. Huang, D.R. Schroeder, J. Alberts, J.L. Cantone, J.H. Sun, P.T. Nower, S.W. Martin, M.H. Serrano-Wu, N.A. Meanwell, L.B. Snyder, and M. Gao. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21576451].
[PubMed]. OV_0513-052611.
10. Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the HCV NS5B Polymerase. Berke, J.M., L. Vijgen, S. Lachau-Durand, M.H. Powdrill, S. Rawe, E. Sjuvarsson, S. Eriksson, M. Gotte, E. Fransen, P. Dehertogh, C. Van den Eynde, L. Leclercq, T.H. Jonckers, P. Raboisson, M. Nilsson, B. Samuelsson, A. Rosenquist, G.C. Fanning, and T.I. Lin. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21576430].
[PubMed]. OV_0513-052611.
11. Antiviral Activity of Acacia Nilotica against Hepatitis C Virus in Liver Infected Cells. Rehman, S., U.A. Ashfaq, S. Riaz, T. Javed, and S. Riazuddin. Virology Journal, 2011. 8(1): p. 220; PMID[21569385].
[PubMed]. OV_0513-052611.
12. Ligand and Structure Based Virtual Screening Strategies for Hit-Finding and Optimization of Hepatitis C Virus (HCV) Inhibitors. Melagraki, G. and A. Afantitis. Current Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21568888].
[PubMed]. OV_0513-052611.
Herpes Simplex virus
13. Anti-Heparan Sulfate Peptides That Block Herpes Simplex Virus Infection in Vivo. Tiwari, V., J. Liu, T. Valyi-Nagy, and D. Shukla. The Journal of biological chemistry, 2011. [Epub ahead of print]; PMID[21596749].
[PubMed]. OV_0513-052611.
14. Inhibition of Herpes Simplex Virus Type 1 and 2 Infection by Peptide-Derivatized Dendrimers. Luganini, A., S.F. Nicoletto, L. Pizzuto, G. Pirri, A. Giuliani, S. Landolfo, and G. Gribaudo. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21576438].
[PubMed]. OV_0513-052611.
15. HSV Neutralization by the Microbicidal Candidate C5a. de Witte, L., M.D. Bobardt, U. Chatterji, F.B. van Loenen, G.M. Verjans, T.B. Geijtenbeek, and P.A. Gallay. Plos One, 2011. 6(5): p. e18917; PMID[21573158].
[PubMed]. OV_0513-052611.
Citations from the ISI Web of Knowledge Listings for O.I.
16. Two New Lignans and Anti-HBV Constituents from Illicium Henryi. Liu, J.F., Z.Y. Jiang, C.A. Geng, Q. Zhang, Y. Shi, Y.B. Ma, X.M. Zhang, and J.J. Chen. Chemistry & Biodiversity, 2011. 8(4): p. 692-698; PMID[ISI:000289859700014].
[WOS]. OV_0513-052611.
17. Tryptamine Derivatives as Novel Non-Nucleosidic Inhibitors against Hepatitis B Virus. Qu, S.J., G.F. Wang, W.H. Duan, S.Y. Yao, J.P. Zuo, C.H. Tan, and D.Y. Zhu. Bioorganic & Medicinal Chemistry, 2011. 19(10): p. 3120-3127; PMID[ISI:000290299100008].
[WOS]. OV_0513-052611.